Abstract
Brucellosis is a highly contagious zoonotic disease and a major human health problem worldwide. Due to its ways of transmission, direct or indirect contact with infected animals or their contaminated biological products, the disease exhibits strong occupational association with animal handlers comprising a significant population at risk. This study was undertaken to estimate the seroprevalence of brucellosis in animal handlers and to understand the epidemiological and serological aspects of the same. The animal handlers from the state of West Bengal, India were included in this study. It was a prospective and observational cohort study from November 2021 to March 2022. A total of 669 sera samples were collected from animal handlers and tested using various serological tests for Brucella antibodies. All serum samples were tested using the Rose Bengal plate test (RBPT), standard tube agglutination test (STAT), and enzyme-linked immunosorbent assay (ELISA). 106 (15.8%) patients were diagnosed with brucellosis among the total number of patients tested. Most of the patients affected with brucellosis belonged to the age group 51–60 years (23.5%). The seropositivity rate in male animal handlers was higher than female animal handlers in this study. More studies are needed to understand the occupational association of this disease. Awareness programs, safe livestock practices, and prevention of the disease by timely diagnosis must be implemented in order to control human brucellosis.
Keywords: Zoonotic disease, brucellosis, animal handlers, seroprevalence
1. Introduction
Brucellosis is one of the most common zoonotic diseases worldwide. Brucellosis is caused by a Gram-negative coccobacilli belonging to the genus Brucella (family Brucellaceae) [1]–[5]. Among the prevalent species, Brucella melitensis, Brucella abortus, Brucella suis and Brucella canis are pathogenic to humans [6],[7]. In humans, the disease is characterized by a variety of manifestations including fever, night sweats, myalgia, arthralgia, and weakness [8]. The wide spectrum of clinical manifestations and the lack of pathognomonic symptoms make human brucellosis difficult to clinically diagnose and distinguish from several febrile conditions that often occur in the same areas. Therefore, laboratory tests are essential for diagnosing the disease. Brucellosis is associated with loss of livestock productivity and trade, thus incurring massive economic losses [9].
In spite of successful eradication attempts in many countries around the world, brucellosis exists as a potent animal and human health issue in developing as well as in developed countries [10]. In developed countries, it is prevalent in wild animals and can be a threat due to spill-over infection potential. Brucellosis is considered an endemic disease in India [9]. Many Indian people have close contact with domestic animals because of their occupation, particularly those involved in agriculture. Therefore, they have an increased risk of contracting many zoonotic diseases including brucellosis [11]. A study by Shukla et al. [12] in different Indian states showed that the overall seroprevalence of brucellosis from tertiary care health settings was 11% (772/7026). The majority of positive cases were from the states of Madhya Pradesh (58.1%), Maharashtra (38.8%) and Chhattisgarh (2.9%). Adults and females were more vulnerable among the study population [12]. Dutta et al. [13] investigated the presence of childhood brucellosis cases in Eastern zone of India. The findings from this study revealed the higher percentage of infection in female children (14.3%) than in male children (10.9%) [13]. Seroprevalence of 8.5% was reported in dairy workers by Mathur in their older study [14]. Looking at studies over time (from 1986 to 2011) there was wide variation of the prevalence of human brucellosis in India, such as 0.8% in Kashmir, 6.8 % in Varanasi, 8.5% in Gujarat, 11.51 % in Andhra Pradesh, 19.83% in Maharashtra, and 26.6 % in Ludhiana [15]–[20]. It is estimated that less than 10% of cases of human brucellosis are recognized and treated in India [21]. A recent rise of the disease in this country has been attributed to intensified developments in the dairy industry resulting in increased livestock population [9]. A high seroprevalence of anti-Brucella antibodies has been noted among veterinarians and veterinary pharmacists [22] in previous studies. Along with veterinary professionals, animal handlers comprise a significant population at risk of contracting brucellosis due to their continued involvement in health and management of livestock.
In India, the veterinary services fall under the purview of the state government. Most of the states have three types of veterinary health care workers: (1) qualified registered veterinarians, (2) paraveterinarians, and (3) animal handlers [23]. The animal handlers are engaged in artificial insemination, vaccination, and deworming of cattle [24] as part of veterinary services. They are consequently exposed to all possible routes of transmission of Brucella spp. including contact with secretions of diseased animals and needle stick injuries while vaccinating female calves. Handling of potentially infected animals, contaminated biological materials, and live attenuated anti-brucellosis vaccines are risk factors for human brucellosis. However, more detailed knowledge about particular risk factors to each occupation, as well as the measurement of these risks is still scarce. In fact, there is a need for more accurate data on the epidemiology of job-related brucellosis to allow the implementation of more effective preventive measures, which will reduce the impact of the disease in groups exposed by their work activities.
There are presently three live Brucella vaccines available commercially: B. abortus strain 19 (S19), B. abortus strain RB51 (RB51), and B. melitensis strain Rev 1 (Rev1) in animals [25]. Among these vaccines, S19 is most commonly used in all vaccination programs in India. It is a modified live culture vaccine [25]. However, Brucella vaccines have been documented to cause human brucellosis if accidental exposure occurs [26].
In India there exists a dearth of studies documenting brucellosis in animal handlers associated with vaccination program. Therefore, the objective of the present study was to (1) estimate the prevalence of brucellosis in animal handlers accidently exposed to S19 vaccine and (2) understand the epidemiological and serological aspect of the same. The serodiagnosis of brucellosis is mostly based on consensual criteria such as given titer in agglutination assay, a cut-off ELISA reading value, etc. Furthermore, the sensitivity and specificity of any serological test for brucellosis depends highly among other factors, on local epidemiological conditions [27]. The results of serological tests for brucellosis require interpretation that is often difficult and inconclusive [28]. Therefore, at least two positives out of three serological tests were used as criteria for diagnosis of brucellosis in surveillance in this study [29].
2. Materials and methods
2.1. Study design and study population
It was a prospective and observational cohort study conducted by the School of Tropical Medicine, Kolkata, India from November 2021–March 2022. The study was done by the Department of Microbiology and Department of Tropical Medicine and was supported by National One Health Program for Prevention and Control of Zoonoses (NOHP-PCZ), National Centre for Disease Control (NCDC), Delhi, India. The target population included animal handlers from the state of West Bengal, India, with a history of accidental exposure to Brucella abortus vaccine (S19 strain). An accidental exposure was defined as a needle stick injection through the skin or sprays or splash into the eye or broken skin of a human while handling the S19 vaccine [30].
2.2. Sample collection
Blood samples (2 mL) were collected from animal handlers reporting to the Outpatient Department of the School of Tropical Medicine (Kolkata) from various districts of West Bengal. Information regarding age, sex, geographic location, type of animal handling activity, history of exposure, clinical history, and other relevant details was obtained after seeking consent from the patients.
2.3. Criteria for positive diagnosis of brucellosis
(a) History of association with animals, with or without symptoms like fever, joint pains, chills, body ache and (b) detection of anti-Brucella antibodies by at least 2 serological tests [29] in significant titers (≥1:160 in case of STAT) [31].
2.4. Methods
Serum was separated from blood samples by centrifuging at 3000 rpm for 5 minutes. The samples were stored at 4 °C until further testing. All serum samples were tested using three serological tests: the Rose Bengal plate test (RBPT), standard tube agglutination test (STAT), and enzyme-linked immunosorbent assay (ELISA).
2.4.1. RBPT
The RBPT is a spot agglutination test. In this test, 30 µL of B. abortus S99 colored antigen and 30 µL of patient serum was taken on a clean glass slide and mixed well. The test was interpreted as negative when agglutination was absent. When agglutination was present, the test was interpreted as positive and rated from 1+ to 3+. This was according to the strength of the agglutination observed from 1–3 minutes [29]. For RBPT, B. abortus S99 colored antigen was procured from Indian Veterinary Research Institute (IVRI, Bareilly), Uttar Pradesh, India.
2.4.2. STAT
For the standard tube agglutination test (STAT), two-fold serial dilutions of the serum samples were prepared from 1:20 to 1:320 according to the Weybridge technique. The highest dilution of the serum exhibiting mat formation was considered as end point titer. A titer of 1:160 and above was considered significant for human brucellosis [29],[31].
2.4.3. ELISA
Indirect ELISA testing for anti-Brucella IgM was performed using a commercially available ELISA kit (NOVALISA, NOVATEC, Germany). The indirect ELISA method was used because of its high sensitivity. The test was performed and results were interpreted as per kit literature.
2.5. Ethical statement
The study was approved (approval number: 2022-AS3) by Institutional Ethics Committee, School of Tropical Medicine, Kolkata, India.
2.6. Statistical analysis
The data obtained in this study was analyzed by R version 4.3.2 by R Foundation for Statistical Computing.
3. Results
In the present study, a total of 669 sera samples were collected from animal handlers and tested using three serological tests (RBPT, STAT, ELISA) for Brucella antibodies. Of these, 106 (15.8%) were diagnosed with brucellosis according to the pre-determined criteria. Among the total number of samples collected, 312 (46.6%) were males and 357 (53.4%) were females. Among those who were seropositive, 53 were male and 53 were female (Table 1). It is interesting to note that 99.7% (310 out of 311) of artificial insemination workers (AI workers) were males.
Table 1. Number and percentage of seropositivity in males and females found in this study.
| Sex | Total Samples Collected | Seropositivity (N %) |
| Males | 312 | 53 (17%) |
| Females | 357 | 53 (14.8%) |
Most of the samples were collected from the age group of 31–40 years (n = 362) followed by 41–50 years (n = 153). The largest percentage of seropositivity was noted in the age group of 51–60 years (23.5%). In this study, 8.8 % seropositivity was found in the age group of 21–30, 14.9% in the age group of 31–40, and 20.3% in the age group of 41–50 (Table 2).
Table 2. Table showing percentage of seropositivity in different age groups of animal handlers.
| Age group (in Years) | Total Samples Collected | Total Samples Seropositive (N %) |
| <20 | 3 | 0 (0%) |
| 21-30 | 90 | 8 (8.8%) |
| 31-40 | 362 | 54 (14.9%) |
| 41-50 | 153 | 31 (20.3%) |
| 51-60 | 51 | 12 (23.5%) |
| >60 | 10 | 1 (10%) |
Regarding district-wise distribution, the largest number of samples were collected from patients from the district of Nadia (166), followed by North 24 Parganas (83), and Bankura (82) of West Bengal. Only one sample was collected from Jhargram and Medinipur district. Among these, the sample from Jhargram was positive and the sample from Medinipur was negative. Among the two samples collected from the Malda district, one was positive and two out of four samples from Paschim Burdwan were positive. Other districts of West Bengal, such as Purba Medinipur (47.6%), Murshidabad (42.4%), Purba Burdwan (26.4%), displayed higher percentages of seropositivity (Table 3).
Table 3. Total seropositivity found in different districts of West Bengal, India.
| Districts of West Bengal | Total Samples Collected | Total seropositivity in each district |
| Bankura | 82 | 13 (15.8%) |
| Birbhum | 24 | 2 (8.3%) |
| Burdwan | 4 | 0 |
| Cooch Behar | 4 | 1 (25%) |
| Hooghly | 30 | 5 (16.6%) |
| Howrah | 25 | 1 (4%) |
| Jhargram | 1 | 1 (100%) |
| Malda | 2 | 1 (50%) |
| Medinipur | 1 | 0 |
| Murshidabad | 33 | 14 (42.4%) |
| North 24 Parganas | 83 | 15 (18%) |
| Nadia | 166 | 19 (11.4%) |
| Purba Burdwan | 34 | 9 (26.4%) |
| Paschim Burdwan | 4 | 2 (50%) |
| Paschim Medinipur | 21 | 4 (19%) |
| Purba Medinipur | 21 | 10 (47.6%) |
| Purulia | 2 | 0 |
| South 24 Parganas | 32 | 4 (12.5%) |
| Uttar Dinajpur | 38 | 2 (5%) |
| Unknown | 62 | 3 (4.8%) |
3.1. Analysis of serological tests
Among the total number of tests performed, RBPT showed positive results in 124 (18.5%) patients. Only RBPT showed a positive result for three (0.4%) of the patients. However, significantly high STAT titers were found in 104 (15.5%) patients. All three tests showed positive results in 91 (13.6%) patients, while two out of the three tests (RBPT and SAT) showed positive results in 13 (1.9%) patients (Table 4).
Table 4. Results of serological tests (RBPT, SAT, and ELISA).
| RBPT | SAT | ELISA | N (%) |
| + | + | + | 91 (13.6%) |
| + | + | - | 13 (1.9%) |
| - | - | - | 535 (79.9%) |
| + | 1:80 | - | 17 (2.5%) |
| + | - | - | 3 (0.4%) |
The overall prevalence of seropositivity was found to be 15.8% (95% confidence interval 13.2 to 18.8). It was not significantly different from the previously reported prevalence of 11% by Shukla et al. [12] with a p value of 0.89. Seropositivity has no association with age (p = 0.22), sex (p = 0.45), type of animal handler (p = 0.32), or mode of exposure (p = 0.13).
4. Discussion
Brucellosis, which is one of the neglected zoonotic diseases with economic importance, is either misdiagnosed or underreported in many parts of the world. Brucellosis has a strong occupational association, with certain professions being more commonly affected by the disease [22]. The disease can lead to serious complications in affected patients with an important public health issue.
Even though the continent of Asia comprises 60% of the world's population with India forming 17%, there are lacunae of studies reporting human brucellosis [9],[32]. There are studies on the concurrent existence of human and animal brucellosis exploring the epidemiology of this disease in veterinary professionals [22],[33]–[35]. However, to the best of our knowledge, there is no study documenting human brucellosis due to possible accidental exposure to the S19 vaccine in the Indian subcontinent. The present study provides valuable insights into occupational brucellosis. A study by Pereira et al. [36] in Minas Gerais, Brazil gives a detailed insight into accidental exposure to S19 and RB51 vaccines. The study revealed that one-third of the interviewed professionals had been accidentally exposed to the vaccine [36].
In the present study, routine serological tests (RBPT, STAT, and ELISA) have been used for the diagnosis of brucellosis. Here, among 669 animal handlers, 106 (15.8%) were diagnosed with brucellosis. The overall prevalence of seropositivity of 15.8% (95% confidence interval 13.2 to 18.8) was not significantly different from the previously reported prevalence of 11% by Shukla et al. [12] with a p value of 0.89. Previously, a high prevalence of occupational brucellosis was found in animal handlers (16.12%) demonstrated by Shome et al. [29], and this was in accordance with our findings. It may be inferred that the lack of knowledge about brucellosis and protective measures among animal handlers increases the probability of infection. The seropositivity distribution observed in males and in females was 17% and 14.8%, respectively (Table 1). This was higher compared to the data reported by Shome et al. [29], where they found 7.45% of males showed seropositivity and none of the females showed seropositivity. In our study, most of the samples were collected from the age group of 31–40 years. However, the highest rate of seropositivity was noted in the age group of 51–60 years (23.5%). The seropositivity was found to be 8.8% in the age group of 21–30, 14.9% in the age group of 31–40, and 20.3% in the age group of 41–50 (Table 2). In this study, the percentage of seropositivity was higher in the age groups of 31–40 and 41–50, compared to the previous study by Shome et al. [29]. High brucellosis seroprevalences were observed in the age groups 21–30 (8.90%), 41–50 (7.85%), and 31–40 (6.75%) by Shome et al. [29]. Regarding districts-wise distribution, the largest numbers of samples were collected from the district of Nadia (166), followed by North 24 Parganas (83) and Bankura (82) of West Bengal. We found variation in the seropositivity rate among the different districts. Statistical analysis showed that seropositivity has no association with age (p = 0.22), sex (p = 0.45), type of animal handler (p = 0.32), or mode of exposure (p = 0.13).
Human brucellosis has been reported earlier among pyrexia of unknown origin (PUO) cases, animal handlers, veterinarians, and slaughterhouse workers in India in some hospital based surveillance studies and case reports [37]–[41]. Our study concurs with the findings of similar studies on accidental exposure to the S19 or RB51 vaccine, where more than half of the target population recalled needle stick injuries [23],[42]. Vaccine bottle opening, syringe capping and recapping, and poor infrastructure were all significant risk factors of acquiring the disease. A study by Proch et al. [24] in India found more occupational brucellosis in veterinary assistants than among veterinarians. In our study, we have solely documented the disease in a cohort of animal handlers with relevant exposures.
The slow growth of Brucella in primary cultures delays diagnosis. Therefore, serological tests play a major role in the routine diagnosis of brucellosis [27],[43]. This was evident in our study when the initial 54 blood cultures of symptomatic patients showed no growth. Most of the diagnostic methods currently used for human serological testing use as antigen, whole “smooth” Brucella cells, or bacterial extracts containing high concentrations of sLPS [25]. Serological tests have problems of false positivity and negativity [27],[44]. Therefore, our study reiterates the fact that a single diagnostic test cannot be used to arrive at a diagnosis of human brucellosis.
Post exposure antibiotic prophylaxis has been recommended for humans accidentally exposed to anti-Brucella vaccines [45]. Based on literature on adverse events linked with vaccination campaigns, it is recommended that those concerned with the administration of this vaccine should wear gloves and eye protection to minimize exposure [26]. In spite of several efforts, the true burden of endemic brucellosis in our subcontinent remains to be seen. As there were no positive growths found in the blood cultures in this study, it could not be concluded if B. abortus strain 19 (S19) was responsible for brucellosis in the animal handlers. Therefore, more studies of human and animal brucellosis across the country are needed to distinguish between the transmission of the disease as a zoonotic disease and its transmission by other routes.
5. Conclusion
Brucellosis is a neglected disease whose problems are underreported worldwide, particularly in South Asia and India. Accidental exposure to the live S19 Brucella vaccine poses a significant threat to animal keepers in the Indian subcontinent. This study showed a seropositivity rate of 15.8% among Indian animal workers, suggesting a lack of awareness and protective measures among them. Female handlers had a seropositivity rate of 14.8%, while the rate of seropositivity for males was 17%. The highest seropositivity was found in the 51- to 60-year-old age group (23.5%). Recommendations include increased awareness, surveillance, improved safety measures through animal handler training, and prioritization of robust diagnostic tests like RBPT both in animals and humans. Moreover, animal brucellosis eradication programs needed to be implemented in order to control human brucellosis since the transmission is zoonotic.
Acknowledgments
Authors thank the technical assistance of Indian Council of Agricultural Research-National Institute of Veterinary Epidemiology and Disease Informatics (ICAR-NIVEDI), Bengaluru, India.
Footnotes
Conflicts of interest: Maria Teresa Mascellino is an editorial board member for AIMS Microbiology and was not involved in the editorial review or the decision to publish this article. All authors declare that there are no competing interests.
Author contributions: Dolanchampa Modak, Silpak Biswas, Malabika Biswas: Conceptualization, Methodology, Investigation and Writing Original Draft, Data curation, Formal Analysis, Writing Review and Editing; Agnibho Mondal: Data curation and Formal Analysis; Maria Teresa Mascellino: Validation, Writing Review and Editing; Banya Chakraborty, Simmi Tiwari, Ajit Dadaji Shewale, Tushar Nale, Rupali Dey: Conceptualization, Supervision, Project Administration, Validation, Writing Review and Editing.
References
- 1.Laine CG, Johnson VE, Scott HM, et al. Global estimate of human brucellosis incidence. Emerg Infect Dis. 2023;29:1789–1797. doi: 10.3201/eid2909.230052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Khuranaa SK, Sehrawata A, Tiwarib R, et al. Bovine brucellosis–a comprehensive review. Vet Q. 2021;41:61–88. doi: 10.1080/01652176.2020.1868616. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Sharma V, Sharma R, Aulakh RS, et al. Prevalence of Brucella species in stray cattle, dogs and cats: A systematic review. Prev Vet Med. 2023;219:106017. doi: 10.1016/j.prevetmed.2023.106017. [DOI] [PubMed] [Google Scholar]
- 4.El-Sayed A, Awad W. Brucellosis: Evolution and expected comeback. Int J Vet Sci Med. 2018;6:31–35. doi: 10.1016/j.ijvsm.2018.01.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Acka PG, Zakowska D, Naylor K, et al. Brucella-virulence factors, pathogenesis and treatment. Pol J Microbiol. 2018;67:151–61. doi: 10.21307/pjm-2018-029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Dadar M, Shahali Y, Whatmore AM. Human brucellosis caused by raw dairy products: A review on the occurrence, major risk factors and prevention. Int J Food Microbiol. 2019;292:39–47. doi: 10.1016/j.ijfoodmicro.2018.12.009. [DOI] [PubMed] [Google Scholar]
- 7.Hayoun MA, Muco E, Shorman M. StatPearls [Internet] Treasure Island (FL): StatPearls Publishing; 2023. Brucellosis. [PubMed] [Google Scholar]
- 8.Dean AS, Crump L, Greter H, et al. Clinical manifestations of human brucellosis: a systematic review and meta-analysis. PLoS Negl. Trop Dis. 2012;6:e1929. doi: 10.1371/journal.pntd.0001929. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Deka P, Magnusson U, Grace D, et al. Bovine brucellosis: prevalence, risk factors, economic cost and controloptions with particular reference to India-a review. Infect Ecol Epidemiol. 2018;9:1556548. doi: 10.1080/20008686.2018.1556548. [DOI] [Google Scholar]
- 10.Jamil T, Akar K, Erdenlig S, et al. Spatio-temporal distribution of brucellosis in european terrestrial and marine wildlife species and its regional implications. Microorganisms. 2022;10:1970. doi: 10.3390/microorganisms10101970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Pandit DP, Pandit PT. Human Brucellosis: Are we neglecting an enemy at the backyard? Med J DY Patil Univ. 2013;350:8. doi: 10.4103/0975-2870.118265. [DOI] [Google Scholar]
- 12.Shukla J, Husain A, Nayak A, et al. Seroprevalence and associated risk factors of human brucellosis from a tertiary care hospital setting in Central India. J Zoo Dis. 2020;4:9–20. https://doi: 10.22034/jzd.2020.11600 . [Google Scholar]
- 13.Dutta D, Sen A, Gupta D, et al. Childhood Brucellosis in Eastern India. Indian J Pediatr. 2018;85:266–271. doi: 10.1007/s12098-017-2513-z. [DOI] [PubMed] [Google Scholar]
- 14.Mathur TN. Brucella strains isolated from cows, buffaloes, goats, sheep and human beings: Their significance with regard to the epidemiology of brucellosis. Indian J Med Res. 1964;52:1231–40. [PubMed] [Google Scholar]
- 15.Panjarathinam R, Jhala CI. Brucellosis in Gujarat State. Indian J Pathol Microbiol. 1986;29:53–60. [PubMed] [Google Scholar]
- 16.Kadri SM, Ruksana A, Laharwal MA, et al. Seroprevalence of brucellosis in Kashmir (India) among patients with pyrexia of unknown origin. J Indian Med Assoc. 2000;98:170–1. [PubMed] [Google Scholar]
- 17.Sen MR, Shukla BN, Goyal RK. Seroprevalence of brucellosis in and around Varanasi. J Commun Dis. 2002;34:226–227. [PubMed] [Google Scholar]
- 18.Mrunalini N, Reddy MS, Ramasastry P, et al. Seroepidemiology of human brucellosis in Andhra Pradesh. Indian Vet J. 2004;81:744–747. [Google Scholar]
- 19.Aher AS, Londhe SP, Bannalikar AS, et al. Detection of brucellosis in occupationally exposed humans by molecular and serological techniques. Indian J Comp Microbiol Immunol Infect Dis. 2011;32:36–40. [Google Scholar]
- 20.Yohannes M, Gill JP. Seroepidemiological survey of human brucellosis in and around Ludhiana, India. Emerg Health Threats J. 2011;28:7361. doi: 10.3402/ehtj.v4i0.7361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Mantur BG, Amarnath SK, Shinde RS. Review of clinical and laboratory features of human Brucellosis. Indian J Med Microbiol. 2007;25:188–202. doi: 10.1016/S0255-0857(21)02105-8. [DOI] [PubMed] [Google Scholar]
- 22.Dadar M, Tabibi R, Alamian S, et al. Safety concerns and potential hazards of occupational brucellosis in developing countries: a review. J Public Health. 2022;31:1–10. doi: 10.1007/s10389-022-01732-0. [DOI] [Google Scholar]
- 23.Tiwari HK, Proch V, Singh BB, et al. Brucellosis in India: Comparing exposure amongst veterinarians, para-veterinarians and animal handlers. One Health. 2021;14:100367. doi: 10.1016/j.onehlt.2021.100367. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Proch V, Singh BB, Schemann K, et al. Risk factors for occupational Brucella infection in veterinary personnel in India. Trans bound Emerg Dis. 2018;00:1–8. doi: 10.1111/tbed.12804. [DOI] [PubMed] [Google Scholar]
- 25.OIE Terrestrial Manual 2016. Brucellosis Chapter 2.1.5. Version adopted by the World Assembly of Delegates of the OIE in May 2016. 2016.
- 26.Food and Agriculture Organization of the United Nations, World Organisation for Animal Health, and World Health Organization. Brucellosis in humans and animals. WHO/CDS/EPR/2006.7. Geneva: World Health Organization; 2006. Available from: http://www.who.int/entity/csr/resources/publications/brucellosis.pdf. [Google Scholar]
- 27.Yagupsky P, Morata P, Colmenero JD. Laboratory diagnosis of human brucellosis. Clin Microbiol Rev. 2019;33:e00073–19. doi: 10.1128/CMR.00073-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Al Dahouk S, Nockler K. Implications of laboratory diagnosis on brucellosis therapy. Expert Rev Anti Infect Ther. 2011;9:833–845. doi: 10.1586/eri.11.55. [DOI] [PubMed] [Google Scholar]
- 29.Shome R, Kalleshamurthy T, Shankaranarayana PB, et al. Prevalence and risk factors of brucellosis among veterinary health care professionals. Pathog Glob Health. 2017;111:234–239. doi: 10.1080/20477724.2017.1345366. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Ashford DA, di Pietra J, Lingappa J, et al. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51. Vaccine. 2004;22:3435–3439. doi: 10.1016/j.vaccine.2004.02.041. [DOI] [PubMed] [Google Scholar]
- 31.Smits HL, Kadri SM. Brucellosis in India: a deceptive infectious disease. Indian J Med Res. 2000;122:375–384. [PubMed] [Google Scholar]
- 32.Nations United. World population prospects—population division—United Nations. 2019. Available from: https://population.un.org/wpp/DataQuery/
- 33.Pathak AD, Dubal ZB, Doijad S, et al. Human brucellosis among pyrexia of unknown origin cases and occupationally exposed individuals in Goa Region, India. Emerg Health Threats J. 2014;7:238–246. doi: 10.3402/ehtj.v7.23846. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Mangtani P, Berry I, Beauvais W, et al. The prevalence and risk factors for human Brucella species infection in a cross-sectional survey of a rural population in Punjab, India. Trans R Soc Trop Med Hyg. 2020;114:255–263. doi: 10.1093/trstmh/trz133. [DOI] [PubMed] [Google Scholar]
- 35.Rahman MM, Islam SMS, Rahman MS, et al. Brucellosis knowledge, awareness and practices among military dairy farm workers in Bangladesh. J. Vet. Med. OH Res. 2022;4:21–32. doi: 10.36111/jvmohr.2022.4(1).0032.1. [DOI] [Google Scholar]
- 36.Pereira CR, de Oliveira IRC, de Oliveira LF, et al. Accidental exposure to Brucella abortus vaccines and occupational brucellosis among veterinarians in Minas Gerais state, Brazil. Transbound Emerg Dis. 2021;68:1363–1376. doi: 10.1111/tbed.13797. [DOI] [PubMed] [Google Scholar]
- 37.Mantur BG, Biradar MS, Bidri RC, et al. Protean clinical manifestations and diagnostic challenges of human brucellosis in adults: 16 years' experience in an endemic area. J Med Microbiol. 2006;55:897–903. doi: 10.1099/jmm.0.46097-0. [DOI] [PubMed] [Google Scholar]
- 38.Mantur B, Amarnath S. Brucellosis in India–A review. J Biosci. 2008;33:539–547. doi: 10.1007/s12038-008-0072-1. [DOI] [PubMed] [Google Scholar]
- 39.Agasthya AS, Isloor S, Prabhudas K. Brucellosis in high risk group individuals. Indian J Med Microbiol. 2007;25:28–31. doi: 10.1016/S0255-0857(21)02230-1. [DOI] [PubMed] [Google Scholar]
- 40.Prakash P, Bhansali S, Gupta E, et al. Epidemiology of brucellosis in high risk group & PUO patients of Western-Rajasthan. Nat J Community Med. 2012;3:61–65. [Google Scholar]
- 41.Kochar DK, Gupta BK, Gupta A, et al. Hospital-based case series of 175 cases of serologically confirmed brucellosis in Bikaner. J Assoc Phys India. 2007;55:271–275. [PubMed] [Google Scholar]
- 42.Kutlu M, Ergonul O, Sayin-Kutlu S, et al. Risk factors for occupational brucellosis among veterinary personnel in Turkey. Pre Vet Med. 2014;117:52–58. doi: 10.1016/j.prevetmed.2014.07.010. [DOI] [PubMed] [Google Scholar]
- 43.Zhai J, Peng R, Wang Y, et al. Factors associated with diagnostic delays in human brucellosis in Tongliao City, Inner Mongolia Autonomous Region, China. Front Public Health. 2021;9:648054. doi: 10.3389/fpubh.2021.648054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Sathyanarayan MS, Suresh DR, Suresh BS, et al. A comparative study of agglutination tests, blood culture & ELISA in the laboratory diagnosis of human brucellosis. Int J Biol Med Res. 2011;2:569–572. [Google Scholar]
- 45.Blasco JM, Diaz R. Brucella melitensis Rev-1 vaccine as a cause of human brucellosis. Lancet. 1993;342:805. doi: 10.1016/0140-6736(93)91571-3. [DOI] [PubMed] [Google Scholar]
